Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Emergent BioSolutions (NYSE:EBS) through any online brokerage.
Other companies in Emergent BioSolutions’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Monopar Therapeutics (NASDAQ:MNPR), Prothena Corp (NASDAQ:PRTA), ADC Therapeutics (NYSE:ADCT) and MapLight Therapeutics (NASDAQ:MPLT).
Emergent BioSolutions has a consensus price target of $14.75.
The stock price for Emergent BioSolutions (NYSE: EBS) is $10.1102 last updated November 14, 2025 at 7:48 PM EST.
There are no upcoming dividends for Emergent BioSolutions.
Emergent BioSolutions’s Q3 earnings are confirmed for Wednesday, October 29, 2025.
There is no upcoming split for Emergent BioSolutions.
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.